Baxter (BAX) is a publicly traded Healthcare sector company. As of July 14, 2026, BAX trades at $21.81 with a market cap of $11.66B and a P/E ratio of -11.59. BAX moved -3.41% today. Year to date, BAX is +14.08%; over the trailing twelve months it is -23.59%. Its 52-week range spans $15.73 to $37.74. Analyst consensus is neutral with an average price target of $21.14. Rallies surfaces BAX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for BAX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $21.81 |
| Market Cap | $11.66B |
| P/E Ratio | -11.59 |
| EPS | $-1.87 |
| Dividend Yield | 0.01% |
| 52-Week High | $37.74 |
| 52-Week Low | $15.73 |
| Volume | 4.20M |
| Avg Volume | 0 |
| Revenue (TTM) | $11.24B |
| Net Income | $-957.00M |
| Gross Margin | 30.05% |
8 analysts cover BAX: 0 strong buy, 2 buy, 5 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $21.14.